TY  - JOUR
AU  - Majem, Margarita
AU  - Cobo, Manuel
AU  - Isla, Dolores
AU  - Marquez-Medina, Diego
AU  - Rodriguez-Abreu, Delvys
AU  - Casal-Rubio, Joaquín
AU  - Bueno, Teresa Moran
AU  - Bernabé-Caro, Reyes
AU  - Parente, Diego Pérez
AU  - Ruiz-Gracia, Pedro
AU  - Arroyo, Marta Marina
AU  - Paz-Ares, Luis
PY  - 2021
DO  - 10.3390/jcm10071365
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/17524
T2  - Journal of clinical medicine
AB  - Programmed cell death-ligand 1 (PD-L1) has emerged as a potential biomarker for selection of patients more likely to respond to immunotherapy and as a prognostic factor in non-small cell lung cancer (NSCLC). In this network meta-analysis, we aimed to...
LA  - en
KW  - PD-(L)1 inhibitors
KW  - efficacy
KW  - first-line treatment
KW  - immunotherapy
KW  - network meta-analysis
KW  - non-small cell lung cancer
TI  - PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis.
TY  - research article
VL  - 10
ER  -